Where Will TJX Companies Stock Be in 10 Years?
Off-price retail is as popular as ever thanks to social…
Buy
63
MMSI Quote, Financials, Valuation and Earnings
Last price:
$102.96
Seasonality move
:
3.03%
Day range:
$101.71 - $103.23
52-week range:
$70.70 - $108.08
Dividend yield:
0%
P/E ratio:
50.20x
P/S ratio:
4.56x
P/B ratio:
4.53x
Volume:
972.6K
Avg. volume:
487.2K
1-year change:
31.99%
Market cap:
$6B
Revenue:
$1.3B
EPS (TTM):
$2.05
Analysts' Opinion
-
Consensus RatingMerit Medical Systems has received a consensus rating of Buy. The company's average rating is a Buy based on 5 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $113.70, Merit Medical Systems has an estimated upside of 10.5% from its current price of $102.90.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $103.00 representing 100% downside risk from its current price of $102.90.
Fair Value
-
According to the consensus of 6 analysts, Merit Medical Systems has 10.5% upside to fair value with a price target of $113.70 per share.
MMSI vs. S&P 500
-
Over the past 5 trading days, Merit Medical Systems has overperformed the S&P 500 by 3.98% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Merit Medical Systems does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Merit Medical Systems has grown year-over-year revenues for 17 quarters straight. In the most recent quarter Merit Medical Systems reported revenues of $339.8M.
Earnings Growth
-
Merit Medical Systems has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Merit Medical Systems reported earnings per share of $0.48.
Enterprise value:
6.2B
EV / Invested capital:
--
Price / LTM sales:
4.56x
EV / EBIT:
35.26x
EV / Revenue:
4.69x
PEG ratio (5yr expected):
2.71x
EV / Free cash flow:
36.04x
Price / Operating cash flow:
35.04x
Enterprise value / EBITDA:
21.77x
Gross Profit (TTM):
$620.9M
Return On Assets:
5.35%
Net Income Margin (TTM):
9.05%
Return On Equity:
9.56%
Return On Invested Capital:
6.16%
Operating Margin:
10.99%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $1.1B | $1.2B | $1.3B | $315.2M | $339.8M | |
| Gross Profit | $513.4M | $567.9M | $620.9M | $142.2M | $157.5M | |
| Operating Income | $102M | $125.2M | $152.6M | $35.7M | $37.4M | |
| EBITDA | $170.7M | $221.5M | $286M | $61.8M | $73.5M | |
| Diluted EPS | $1.08 | $1.73 | $2.05 | $0.44 | $0.48 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $434.6M | $463.4M | $499.9M | $585.3M | $1.1B | |
| Total Assets | $1.7B | $1.6B | $1.6B | $1.8B | $2.4B | |
| Current Liabilities | $186M | $213.5M | $213M | $187.1M | $201.1M | |
| Total Liabilities | $736.7M | $629.8M | $543.9M | $578.6M | $1.1B | |
| Total Equity | $933.8M | $1B | $1.1B | $1.2B | $1.3B | |
| Total Debt | $357.3M | $278.7M | $216.7M | $286.1M | $750.5M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $132.1M | $110.9M | $214.3M | $51.1M | $47.3M | |
| Cash From Investing | -$54.7M | -$184.3M | -$162.5M | -$9.3M | -$115.7M | |
| Cash From Financing | -$87M | $80.7M | $410.4M | -$54.6M | -$47.6M | |
| Free Cash Flow | $88.6M | $68.2M | $172.7M | $41.8M | $37.4M | |
MMSI
Sector
Market Cap
$6B
$45.2M
Price % of 52-Week High
95.21%
46.55%
Dividend Yield
0%
0%
Shareholder Yield
-1.77%
-0.75%
1-Year Price Total Return
31.99%
-33.5%
Beta (5-Year)
0.850
0.747
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$99.02
200-day SMA
Buy
Level
$90.49
Bollinger Bands (100)
Buy
Level
95.38 - 102.42
Chaikin Money Flow
Buy
Level
89.2M
20-day SMA
Buy
Level
$97.82
Relative Strength Index (RSI14)
Buy
Level
61.85
ADX Line
Buy
Level
26.63
Williams %R
Sell
Level
-3.9474
50-day SMA
Buy
Level
$101.19
MACD (12, 26)
Buy
Level
0.00
25-day Aroon Oscillator
Sell
Level
-80
On Balance Volume
Neutral
Level
74.8M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8828)
Buy
CA Score
(Annual)
Level (0.4754)
Buy
Beneish M-Score
(Annual)
Level (-2.8768)
Buy
Momentum Score
Level (9)
Buy
Ohlson Score
Level (-0.8847)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for use in interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment. The United States generates the majority of the revenue.
Stock Forecast FAQ
In the current month, MMSI has received 5 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MMSI average analyst price target in the past 3 months is $113.70.
-
Where Will Merit Medical Systems Stock Be In 1 Year?
According to analysts, the consensus estimate is that Merit Medical Systems share price will rise to $113.70 per share over the next 12 months.
-
What Do Analysts Say About Merit Medical Systems?
Analysts are divided on their view about Merit Medical Systems share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Merit Medical Systems is a Sell and believe this share price will drop from its current level to $103.00.
-
What Is Merit Medical Systems's Price Target?
The price target for Merit Medical Systems over the next 1-year time period is forecast to be $113.70 according to 6 Wall Street analysts, 5 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MMSI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Merit Medical Systems is a Buy. 5 of 6 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of MMSI?
You can purchase shares of Merit Medical Systems via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Merit Medical Systems shares.
-
What Is The Merit Medical Systems Share Price Today?
Merit Medical Systems was last trading at $102.96 per share. This represents the most recent stock quote for Merit Medical Systems. Yesterday, Merit Medical Systems closed at $102.90 per share.
-
How To Buy Merit Medical Systems Stock Online?
In order to purchase Merit Medical Systems stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will CVS Health Stock Recover?
It’s been a treacherous journey for CVS Health Corporation (NYSE:CVS)…
Why Is AT&T Stock Dropping?
The telecommunications giant AT&T Inc. (NYSE:T) has perhaps surprisingly eclipsed…
Stock Ideas
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 38x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 115x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 36x
Alerts
Sell
45
QMCO alert for Jan 18
Quantum [QMCO] is down 15.61% over the past day.
Buy
51
QRVO alert for Jan 18
Qorvo [QRVO] is up 14.47% over the past day.
Sell
31
ATEX alert for Jan 18
Anterix [ATEX] is up 11.14% over the past day.
